Skip to main content

TiUnite implant surface – proven to perform

Enhanced osseointegration and stable bone levels

Contact us

What is TiUnite?

TiUnite is a high-performance implant surface that enhances osseointegration1 – even under the most challenging conditions.2-8 It is characterized by a moderately rough, thickened titanium oxide layer with high crystallinity and osteoconductive properties leading to faster bone formation.

5 reasons to choose implants with the TiUnite surface

Unparalleled scientific evidence

TiUnite is one of the most clinically researched implant surfaces on the market. Since its launch in 2000, it has been clinically documented in more than 465 publications on 382 clinical studies evaluating more than 89,500 implants, over 22,600 patients, and 11.2 years of longest mean follow-up.12

Predictable osseointegration with minimal failure rates

The TiUnite implant surface was first introduced on the Brånemark System in 2000. This shift from machined to TiUnite surface resulted in a clear decrease in early failures, especially in areas with poor bone density.14,15

Stable marginal bone levels

After the initial bone remodeling phase, the TiUnite implant surface has shown stable marginal bone levels over the medium and long-term.13,16

Short- and long-term success

TiUnite maintains implant stability immediately after placement with enhanced osseointegration and anchorage in surrounding bone.1,9,17 In the long term, it maintains marginal bone and soft tissue levels, maximizing functional endurance and esthetics.13,16,18-23

Low rates of peri-implantitis

The TiUnite implant surface demonstrated low prevalence of peri-implantitis24 at a rate comparable with other moderately rough implant surfaces.13,25

"The meta-analysis is another validation of TiUnite’s efficacy, but there is confirmation of its high performance also in other types of clinical studies. I observed TiUnite being launched in the year 2000. I believed in it then and now I know that my beliefs were correct. It is a superb implant surface."

Professor Tomas Albrektsson, Sweden

NobelActive supporting hard and soft tissue for 10 years

Immediate implant placement in a fresh extraction socket of a NobelActive RP implant 4.3 mm x 13 mm. Socket augmentation was performed, using xenograft and autogenous soft-tissue grafting harvested from the tuberosity area, to close the socket and increase the amount of soft tissue at the recipient site. A cement-retained lithium disilicate crown was cemented onto an anatomically shaped zirconia abutment.